Cortex Pharmaceutic Stock Shares Owned By Institutions
| PHXDelisted Stock | USD 4.35 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess CORTEX PHARMACEUTIC's long-term financial health and intrinsic value.
CORTEX |
CORTEX PHARMACEUTIC Company Shares Owned By Institutions Analysis
CORTEX PHARMACEUTIC's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current CORTEX PHARMACEUTIC Shares Owned By Institutions | 69.39 % |
Most of CORTEX PHARMACEUTIC's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CORTEX PHARMACEUTIC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
CompetitionBased on the latest financial disclosure, 69% of CORTEX PHARMACEUTIC are shares owned by institutions. This is 82.17% higher than that of the Oil, Gas & Consumable Fuels sector and 36.81% higher than that of the Energy industry. The shares owned by institutions for all Germany stocks is 76.97% lower than that of the firm.
CORTEX Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CORTEX PHARMACEUTIC's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CORTEX PHARMACEUTIC could also be used in its relative valuation, which is a method of valuing CORTEX PHARMACEUTIC by comparing valuation metrics of similar companies.CORTEX PHARMACEUTIC is currently under evaluation in shares owned by institutions category among its peers.
CORTEX Fundamentals
| Return On Equity | 0.0555 | |||
| Return On Asset | 0.0185 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | (0.04) % | |||
| Current Valuation | 182.81 M | |||
| Shares Outstanding | 37.92 M | |||
| Shares Owned By Insiders | 15.10 % | |||
| Shares Owned By Institutions | 69.39 % | |||
| Number Of Shares Shorted | 123.3 K | |||
| Price To Earning | 21.21 X | |||
| Price To Book | 1.31 X | |||
| Price To Sales | 4.58 X | |||
| Revenue | 34.27 M | |||
| Gross Profit | 30.11 M | |||
| EBITDA | 15.32 M | |||
| Net Income | 2.32 M | |||
| Cash And Equivalents | 3.4 M | |||
| Cash Per Share | 0.12 X | |||
| Total Debt | 30.2 M | |||
| Debt To Equity | 0.30 % | |||
| Current Ratio | 1.49 X | |||
| Book Value Per Share | 3.44 X | |||
| Cash Flow From Operations | 18.08 M | |||
| Short Ratio | 0.13 X | |||
| Earnings Per Share | 0.19 X | |||
| Target Price | 4.35 | |||
| Number Of Employees | 18 | |||
| Beta | 0.064 | |||
| Market Capitalization | 164.96 M | |||
| Total Asset | 163.92 M | |||
| Retained Earnings | 77.07 M | |||
| Working Capital | 6.32 M | |||
| Current Asset | 6.57 M | |||
| Current Liabilities | 4.47 M | |||
| Annual Yield | 0.04 % | |||
| Five Year Return | 1.88 % | |||
| Net Asset | 163.92 M | |||
| Last Dividend Paid | 0.15 |
About CORTEX PHARMACEUTIC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CORTEX PHARMACEUTIC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CORTEX PHARMACEUTIC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CORTEX PHARMACEUTIC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in CORTEX Stock
If you are still planning to invest in CORTEX PHARMACEUTIC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CORTEX PHARMACEUTIC's history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |